ARS Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
26 Aug 24 | SellUS$1,088,035 | OrbiMed Advisors LLC | Company | 83,695 | US$13.00 | |
23 Aug 24 | SellUS$11,497,963 | OrbiMed Advisors LLC | Company | 868,682 | US$14.61 | |
27 Mar 24 | BuyUS$13,289,410 | RA Capital Management, L.P. | Company | 1,401,299 | US$9.79 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 2,845,946 | 2.94% |
Hedge Funds | 11,077,927 | 11.4% |
General Public | 12,237,364 | 12.6% |
Individual Insiders | 19,120,917 | 19.7% |
VC/PE Firms | 19,149,487 | 19.8% |
Institutions | 32,509,968 | 33.5% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
11,077,927 | US$157.2m | 0% | 2.41% | |||
10,860,977 | US$154.1m | 0% | 1.77% | |||
8,288,510 | US$117.6m | -10.3% | 1.61% | |||
5,711,807 | US$81.1m | -2.56% | no data | |||
4,824,554 | US$68.5m | -52.5% | no data | |||
4,213,504 | US$59.8m | 0% | no data | |||
4,084,339 | US$58.0m | 53.7% | no data | |||
4,012,903 | US$56.9m | 0% | 11.09% | |||
3,407,847 | US$48.4m | 0% | no data | |||
3,250,927 | US$46.1m | 12.6% | no data | |||
2,950,709 | US$41.9m | 0% | 0.01% | |||
2,845,946 | US$40.4m | -13.7% | no data | |||
2,461,672 | US$34.9m | 10.9% | 16.63% | |||
1,910,029 | US$27.1m | 0% | 4.05% | |||
1,856,221 | US$26.3m | 15.7% | no data | |||
1,195,878 | US$17.0m | 36.4% | no data | |||
1,085,318 | US$15.4m | 0.04% | no data | |||
867,319 | US$12.3m | 0% | 0.28% | |||
696,665 | US$9.9m | 9.03% | 0.56% | |||
645,700 | US$9.2m | 15.6% | 0.08% | |||
639,203 | US$9.1m | 0% | 0.15% | |||
415,530 | US$5.9m | 20.3% | no data | |||
406,188 | US$5.8m | 1.67% | no data | |||
382,236 | US$5.4m | 0% | no data | |||
365,027 | US$5.2m | 31.4% | 0.02% |